CLINICAL_TRIALS
trial_result
· 2023-08-09
Clinical Trial Update: Safety and Efficacy of IBI306 in HeFH Patients [Phase 3]
Summary
Phase 3 trial update on IBI306 in patients with heterozygous familial hypercholesterolemia assessing safety and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Heterozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED